Farmakhem B.V. (full-cycle manufacturing)

Ukraine

All drugs from this manufacturer

  • CISPLATIN-TEVA

    The drug is used to treat common or metastatic malignant tumors, including testicular cancer, ovarian cancer (stages III and IV), bladder carcinoma, squamous cell epithelioma of the head and neck, lung cancer, and cervical tumors.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    cisplatin 0.5 mg/ml

    ATC: L01XA01

  • CISPLATIN-TEVA

    The drug is used to treat common or metastatic malignant tumors, including testicular cancer, ovarian cancer (stages III and IV), bladder carcinoma, squamous cell epithelioma of the head and neck, lung cancer, and cervical tumors.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    cisplatin 1 mg/ml

    ATC: L01XA01

  • METHOTREXATE-TEVA

    The drug is used to treat various types of tumors (e.g., leukemia, osteosarcoma, lymphoma, breast cancer), as well as for the therapy of severe forms of psoriasis and rheumatoid arthritis.

    Dosage form: solution for injection

    Active substance Dosage
    methotrexate 100 mg/ml

    ATC: L01BA01

  • METHOTREXATE-TEVA

    The drug is used to treat various types of cancer (e.g., leukemia, osteosarcoma, lymphoma, breast cancer), trophoblastic tumors, as well as severe forms of psoriasis and rheumatoid arthritis.

    Dosage form: solution for injection

    Active substance Dosage
    methotrexate 25 mg/ml

    ATC: L01BA01